1-16 of 16
antiplatelet agents
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Underuse of Medications and Lifestyle Counseling to Prevent Cardiovascular Disease in Patients With Diabetes

Jonathan D. Newman, Jeffrey S. Berger, Joseph A. Ladapo
Journal: Diabetes Care
Diabetes Care 2019;42(5):e75–e76
https://doi.org/10.2337/dc18-1554
Published: 12 March 2019
View article titled, Underuse of Medications and Lifestyle Counseling to Prevent Cardiovascular Disease in Patients With Diabetes
Open the PDF for Underuse of Medications and Lifestyle Counseling to Prevent Cardiovascular Disease in Patients With Diabetes in another window
Journal Articles

Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010–2015

Alanna V. Rigobon, Sumeet Kalia, Jennica Nichols, Babak Aliarzadeh, Michelle Greiver, Rahim Moineddin, Frank Sullivan, Catherine Yu
Journal: Diabetes Care
Diabetes Care 2019;42(1):148–156
https://doi.org/10.2337/dc18-0935
Published: 02 November 2018
View article titled, Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010–2015
Open the PDF for Impact of the Diabetes Canada Guideline Dissemination Strategy on the Prescription of Vascular Protective Medications: A Retrospective Cohort Study, 2010–2015 in another window
Includes: Supplementary data
Journal Articles

Summary of Revisions to the 2014 Clinical Practice Recommendations

Journal: Diabetes Care
Diabetes Care 2014;37(Supplement_1):S4
https://doi.org/10.2337/dc14-S004
Published: 16 December 2013
View article titled, Summary of Revisions to the 2014 Clinical Practice Recommendations
Open the PDF for Summary of Revisions to the 2014 Clinical Practice Recommendations in another window
Journal Articles

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes

Dimitrios Alexopoulos, MD, Ioanna Xanthopoulou, MD, Eleni Mavronasiou, MD, Katerina Stavrou, MD, Argyro Siapika, MD, Evropi Tsoni, MD, Periklis Davlouros, MD
Journal: Diabetes Care
Diabetes Care 2013;36(8):2211–2216
https://doi.org/10.2337/dc12-2510
Published: 11 July 2013
View article titled, Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
Open the PDF for Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes in another window
Journal Articles

Antiplatelet Therapy for Every Diabetic Person?

Antonio Nicolucci, MD, Eberhard Standl, MD
Journal: Diabetes Care
Diabetes Care 2011;34(Supplement_2):S150–S154
https://doi.org/10.2337/dc11-s210
Published: 22 April 2011
View article titled, Antiplatelet Therapy for Every Diabetic Person?
Open the PDF for Antiplatelet Therapy for Every Diabetic Person? in another window
Journal Articles

Summary of Revisions for the 2010 Clinical Practice Recommendations

Journal: Diabetes Care
Diabetes Care 2010;33(Supplement_1):S3
https://doi.org/10.2337/dc10-S003
Published: 01 January 2010
View article titled, Summary of Revisions for the 2010 Clinical Practice Recommendations
Open the PDF for Summary of Revisions for the 2010 Clinical Practice Recommendations in another window
Journal Articles

Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes

Caroline Sirois, BPHARM, MSC, Jocelyne Moisan, PHD, Paul Poirier, MD, PHD, Jean-Pierre Grégoire, MPH, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(7):1880–1882
https://doi.org/10.2337/dc06-2257
Published: 01 July 2007
View article titled, Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
Open the PDF for Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes in another window
Journal Articles

The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes

Charlotte G. McDonald, MD, MSC, FRCPC, Sumit R. Majumdar, MD, MPH, FRCPC, Jeffrey L. Mahon, MD, MSC, FRCPC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(9):2113–2117
https://doi.org/10.2337/diacare.28.9.2113
Published: 01 September 2005
View article titled, The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes
Open the PDF for The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

It Can Be Done

Robert C. Hood, MD, FRCP(C), FACE
Journal: Diabetes Care
Diabetes Care 2003;26(12):3359–3360
https://doi.org/10.2337/diacare.26.12.3359
Published: 01 December 2003
View article titled, It Can Be Done
Open the PDF for It Can Be Done in another window
Journal Articles

Peripheral Arterial Disease in People With Diabetes

American Diabetes Association
Journal: Diabetes Care
Diabetes Care 2003;26(12):3333–3341
https://doi.org/10.2337/diacare.26.12.3333
Published: 01 December 2003
View article titled, Peripheral Arterial Disease in People With Diabetes
Open the PDF for Peripheral Arterial Disease in People With Diabetes in another window
Journal Articles

The Platelet in Diabetes: Focus on prevention of ischemic events

John A. Colwell, MD, PHD, Richard W. Nesto, MD
Journal: Diabetes Care
Diabetes Care 2003;26(7):2181–2188
https://doi.org/10.2337/diacare.26.7.2181
Published: 01 July 2003
View article titled, The Platelet in Diabetes: <subtitle>Focus on prevention of ischemic events</subtitle>
Open the PDF for The Platelet in Diabetes: <subtitle>Focus on prevention of ischemic events</subtitle> in another window
Journal Articles

Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: An intervention trial

Alessandro Filippi, MD, Andrea Sabatini, Letizia Badioli, Fabio Samani, MD, Giampiero Mazzaglia, MD, PHD, MSC, Alberico Catapano, PHD, Claudio Cricelli, MD
Journal: Diabetes Care
Diabetes Care 2003;26(5):1497–1500
https://doi.org/10.2337/diacare.26.5.1497
Published: 01 May 2003
View article titled, Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: <subtitle>An intervention trial </subtitle>
Open the PDF for Effects of an Automated Electronic Reminder in Changing the Antiplatelet Drug–Prescribing Behavior Among Italian General Practitioners in Diabetic Patients: <subtitle>An intervention trial </subtitle> in another window
Journal Articles

Control of Cardiovascular Risk Factors in Patients With Diabetes and Hypertension at Urban Academic Medical Centers

Samy I. McFarlane, MD, Scott J. Jacober, DO, Nathaniel Winer, MD, Jasjeet Kaur, MD, Jonathan P. Castro, MD, MaryLou A. Wui, MD, Agnes Gliwa, MD, Hans Von Gizycki, James R. Sowers, MD
Journal: Diabetes Care
Diabetes Care 2002;25(4):718–723
https://doi.org/10.2337/diacare.25.4.718
Published: 01 April 2002
View article titled, Control of Cardiovascular Risk Factors in Patients With Diabetes and Hypertension at Urban Academic Medical Centers
Open the PDF for Control of Cardiovascular Risk Factors in Patients With Diabetes and Hypertension at Urban Academic Medical Centers in another window
Meeting Abstracts

Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.

T Nakamura, C Ushiyama, N Shimada, K Sekizuka, I Ebihara, M Hara, H Koide
Journal: Diabetes Care
Diabetes Care 2000;23(8):1168–1171
https://doi.org/10.2337/diacare.23.8.1168
Published: 01 August 2000
View article titled, Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.
Open the PDF for Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy. in another window
Journal Articles

Veterans Administration Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: II. Effects of Aspirin and Dipyridamole on Atherosclerotic Vascular Disease Rates

John A Colwell, M.D., Ph.D., Stephen F Bingham, Ph.D., Carlos Abraira, M.D., James W Anderson, M.D., John P Comstock, M.D., Hau C Kwaan, M.D., Frank Nuttall, M.D., Ph.D., The Cooperative Study Group
Journal: Diabetes Care
Diabetes Care 1986;9(2):140–148
https://doi.org/10.2337/diacare.9.2.140
Published: 01 March 1986
View article titled, Veterans Administration Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: II. Effects of Aspirin and Dipyridamole on Atherosclerotic Vascular Disease Rates
Open the PDF for Veterans Administration Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: II. Effects of Aspirin and Dipyridamole on Atherosclerotic Vascular Disease Rates in another window
Journal Articles

Diabetic Microangiopathic Hemolytic Anemia: Beneficial Effect of an Antiplatelet Agent?

Alain G Dupont, M.D., Patricia Van Der Niepen, M.D., Jacques Sennesael, M.D., Guido Somers, Ph.D.
Journal: Diabetes Care
Diabetes Care 1985;8(2):169–171
https://doi.org/10.2337/diacare.8.2.169
Published: 01 March 1985
View article titled, Diabetic Microangiopathic Hemolytic Anemia: Beneficial Effect of an Antiplatelet Agent?
Open the PDF for Diabetic Microangiopathic Hemolytic Anemia: Beneficial Effect of an Antiplatelet Agent? in another window